Resources
12 entries. Each is tagged with what it actually is, so you know whether you are about to open a guideline, a study, or an advocacy organization before you click — and each carries the date it was last checked. Curated rather than comprehensive: the aim is the handful of things worth reading first.
Diagnostic criteria & guidelines
-
Diagnosis of mast cell activation syndrome: a global "consensus-2"
2021 Recently verified. Verified 20 Aug 2026The broader of the two criteria sets in active use. Read alongside the AAAAI work group report below — the two admit meaningfully different patient populations, and which one a clinician applies changes who receives a diagnosis.
-
AAAAI Mast Cell Disorders Committee Work Group Report: MCAS diagnosis and management
2019 Recently verified. Verified 20 Aug 2026The narrower criteria set, requiring objective evidence of mast cell mediator release with a documented rise from baseline. The reference point for most US allergy and immunology practice.
Key papers
-
Using the Right Criteria for MCAS
2024 Recently verified. Verified 20 Aug 2026Directly addresses the disagreement between the two criteria sets and what turns on it. The single most useful paper for understanding why sources on this topic contradict each other.
-
Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis
2020 Recently verified. Verified 20 Aug 2026Practical review of the diagnostic workup and, importantly, of the conditions that present similarly and are more common.
-
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management
2019 Recently verified. Verified 20 Aug 2026The management review most of this site's medication entries lean on. Covers the stepwise mediator-blockade approach and where the evidence for each step actually comes from.
-
Mast Cell Activation Syndrome (Clinical Reviews in Allergy & Immunology)
2018 Recently verified. Verified 20 Aug 2026Broad background review covering mediators, presentation, and the state of the evidence base.
Patient organizations
-
European Competence Network on Mastocytosis (ECNM)
Recently verified. Verified 20 Aug 2026Network of European reference centres for mast cell disease. Useful for locating specialist centres and for following the research consortium's output.
-
Mast Cell Action
Recently verified. Verified 20 Aug 2026UK charity focused on MCAS specifically. Publishes patient-facing resources and materials intended to be taken to appointments.
-
Mastocytosis Society Canada
Recently verified. Verified 20 Aug 2026Canadian patient organization for mast cell disease, with region-specific care and emergency information.
-
The Mast Cell Disease Society (TMS)
Recently verified. Verified 20 Aug 2026US non-profit for mastocytosis and mast cell activation disorders. Maintains physician referral lists, emergency-protocol documents, and patient education material.
Registries
-
ClinicalTrials.gov
Recently verified. Verified 20 Aug 2026The primary registry, and the source this site uses for every trial status. Worth searching directly rather than relying on secondary trackers, which go stale without indicating that they have.
Practitioner-authored resources
-
Mast Cell 360 low-histamine food list
Recently verified. Verified 20 Aug 2026One of the most widely circulated low-histamine food lists, compiled by a practitioner from published research and clinical experience. Included because patients often arrive having already followed it, and because it illustrates what the 2021 review documents: several foods it groups as higher-histamine have no detectable histamine on analysis.